RG6333 (CD19-CD28), a CD19-Targeted Affinity-Optimized CD28 Bispecific Antibody, Enhances and Prolongs the Anti-Tumor Activity of Glofitamab (CD20-TCB) in Preclinical ModelsJohannes Sam,Thomas Hofer, Christine Kuettel,Christina Claus,Sylvia Herter,Guy Georges, Jenny Tosca Thom,Leo Kunz, Samuel Gebhardt,Florian Limani,Stefanie Briner,Silvia Jenni,Anne Schoenle,Marine Le Clech,Ahmet Varol,Esther Bommer,Birte Appelt,Sara Colombetti,Stephan Gasser,Marina Bacac,Christian Klein,Pablo UmanaBLOOD（2022）引用 3|浏览34AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
